SCHEMBL8993227

SCHEMBL8993227

CCOC(=O)c1ccc(Cc2ccccc2C)c(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.58
SMN1; SMN2 Q16637 6/20 0.53
RAB9A P51151 5/20 0.53
NPC1 O15118 3/20 0.53
MAPT P10636 7/20 0.48
MEN1 O00255 6/20 0.48
KMT2A Q03164 6/20 0.48
HTT P42858 2/20 0.48
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 4/20 0.46
POLB P06746 2/20 0.46
LMNA P02545 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
TSHR P16473 2/20 0.45
CDC25B P30305 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8992779 0.92 HSD17B2 (0.61) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8993326 0.83 HSD17B2 (0.59) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8992999 0.82 HSD17B2 (0.58) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL14582858 0.80 HSD17B2 (0.68) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL5161173 0.79 HSD17B2 (0.66) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL10945118 0.78 HSD17B2 (0.73) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL3904758 0.77 HSD17B2 (0.62) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL30506315 0.77 HSD17B2 (0.76) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL1660365 0.77 HSD17B2 (0.76) HSD17B2SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL9301797 0.76 RAB9A (0.58) HSD17B2SMN1; SMN2RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516777-A PROSTATE CANCER THERAPY OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-05-14 US disclosed
US-5409928-A Prostate diseases, alopecia OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-04-25 US disclosed
EP-0594149-A2 Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-04-27 EP disclosed